Prospective randomized trial of transthoracic versus low-energy internal cardioversion in persistent atrial fibrillation: Long term follow-up

International Heart Journal

Volumn 47, Issue 5, 2006, Pages 753-762

  Özdemir, Murat ^a   Türkoǧlu, Sedat ^a   Kaya, Mehmet Güngör ^a   Çengel, Atiye ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Low energy internal cardioversion

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; PROPAFENONE; SOTALOL; VERAPAMIL; WARFARIN;

ADULT; AGED; ARTICLE; BALLOON CATHETER; BLEEDING; CARDIOVERSION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTRICITY; ELECTRODE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; SEDATION; SINUS RHYTHM; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WARFARIN;

EID: 33751176071     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.47.753     Document Type: Article

References (27)

1. Wyse DG, Waldo AL, DiMarco JP, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-33.
2. Van Gelder IC, Hagens VE, Bosker HA, et al; Rate control versus electrical cardioversion for persistent atrial fibrillation study group. N Engl J Med 2002; 347: 1834-40.
3. Carlsson J, Miketic S, Windeler J, et al; STAF Investigators. Randomized trial of rate-control versus rhythmcontrol in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003; 41: 1690-6.
4. Levy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation. (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997; 29: 750-5.
5. Socas AG, Ricard P, Taramasco V, Guenoun M, Levy S. Transvenous cardioversion of atrial fibrillation using low-energy shocks. J Interv Card Electrophysiol 1997; 1: 125-9.
6. Boriani G, Biffi M, Pergolini F, Zannoli R, Branzi A, Magnani B. Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year. Pacing Clin Electrophysiol 1999; 22: 243-6.
7. Santini M, Pandozi C, Toscano S, et al. Low energy intracardiac cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 1998; 21: 2641-50.
8. Boriani G, Biffi M, Bronzetti G, et al. Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol 1998; 81: 241-4.
9. Alt E, Ammer R, Schmitt C, et al. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J 1997; 18: 1796-804.
10. Yalcin R, Kaya MG, Ozdemir M, et al. Prospective randomized trial of transthoracic versus low-energy transvenous internal cardioversion in persistent atrial fibrillation. Acta Cardiol 2004; 59: 521-6.
11. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852-923.
12. Siaplaouras S, Jung J, Buob A, Heisel A. Incidence and management of early recurrent atrial fibrillation (ERAF) after transthoracic electrical cardioversion. Europace 2004; 6: 15-20.
13. Sharp JC, Whalley DW. Effectiveness and safety of low-energy internal cardioversion of long-standing atrial fibrillation after unsuccessful external cardioversion. Am J Cardiol 2002; 90: 657-60.
14. Schmitt C, Alt E, Plewan A, et al. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol 1996; 28: 994-9.
15. Tse HF, Lau CP, Ayers GM. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart 1999; 82: 319-24.
16. Timmermans C, Rodriguez LM, Smeets JL, Wellens HJ. Immediate remitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 1998; 9: 122-8.
17. Goktekin O, Melek M, Timuralp B, et al. Internal cardioversion of atrial fibrillation under transesophageal echocardiography guidance without fluoroscopy using single-lead catheter technique. Am J Cardiol 2002; 90: 328-31.
18. Van Gelder IC, Crijns HJ. Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. Pacing Clin Electrophysiol 1997; 20: 2675-83. (Review)
19. Tse HF, Lau CP, Ayers GM. Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion. Am J Cardiol 1999; 83: 607-9.
20. Levy S, Ricard P, Gueumoun M, et al. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. Circulation 1997; 96: 253-9.
21. Alt E, Ammer R, Lehmann G, Schmitt C, Pasquantonio J, Schomig A. Efficacy of a new balloon catheter for internal cardioversion of chronic atrial fibrillation without anaesthesia. Heart 1998; 79: 128-32.
22. Biffi K Boriani G, Bartolotti K Reggiani LB, Zarmoli R, Branzi A. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart 2002; 87: 443-8.
23. Gasparini G, Bonso A, Themistoclakis S, Giada F, Raviele A. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up. Europace 2001; 3: 90-5.
24. Levy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992; 86: 1415-20.
25. Paravolidakis KE, Kolettis TM, Theodorakis GN, Paraskevaidis IA, Apostolou TS, Kremastinos DT. Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation. J Interv Card Electrophysiol 1998; 2: 249-53.
26. Levy S, Lacombe P, Cointe R, Bru P. High energy transcatheter cardioversion of cbronic: atrial fibrillation. J Am Coll Cardiol 1988; 12: 514-8.
27. Alt E, Ammer R, Lehmann G, et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 1997; 134: 419-25.